Skip to main content
main-content

Stephen Liu

Dr. Stephen Liu, MD, is an Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics at the Lombardi Comprehensive Cancer Center of Georgetown University.

Latest contributions from Stephen Liu

06-12-2021 | Non-small-cell lung cancer | Interview | Article

ARROW points the way for RET fusion-positive NSCLC treatment

Stephen Liu outlines the ARROW study design and findings and discusses the impact of pralsetinib on the care of patients with treatment-naïve and previously treated NSCLC positive for a RET fusion (7:20).

05-06-2021 | ASCO 2021 | Conference coverage | Video

ARROW update confirms pralsetinib benefit for RET fusion-positive advanced NSCLC

Stephen Liu talks through the latest findings from the ARROW trial of pralsetinib for patients with RET fusion-positive advanced non-small-cell lung cancer.

04-02-2021 | Small-cell lung cancer | News

Novel immune agent shows early promise in SCLC

AMG 757, a half-life extended, bispecific T-cell engager immunotherapy directed against DLL3, has demonstrated tolerability and antitumor activity in patients with previously treated small-cell lung cancer in a phase 1 trial.

27-01-2021 | COVID-19 | News

NCCN issues guidance for COVID-19 vaccination in cancer patients

The COVID-19 Vaccination Advisory Committee of the US National Comprehensive Cancer Network has provided preliminary recommendations for COVID-19 vaccinations in people with cancer.

Image Credits